Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 210642
Company: AUROBINDO PHARMA LTD
Company: AUROBINDO PHARMA LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE | ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE | 600MG;50MG;300MG | TABLET;ORAL | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/12/2023 | ORIG-1 | Tentative Approval | STANDARD |
Label is not available on this site. |